Dabucon, Nereka M.
HRN: 25-35-45 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2025
LEVOFLOXACIN 500MG (TAB)
01/17/2025
01/20/2025
PO
500 Mg
Q48 Hrs
Acute GN
Waiting Final Action